Article Details

Late-stage asthma pipeline partially addresses needs for personalised and convenient medications

Retrieved on: 2021-03-26 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Late-stage asthma pipeline partially addresses needs for personalised and convenient medications. View article details on hiswai:

Excerpt

There are several monoclonal antibodies (Cinquair/Cinqaero, Fasenra and Dupixent) currently at the beginning of their lifecycles, and one ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo